GSK seeks FDA nod for expanded use of RSV vaccine in adults

• click to rate

  Posted by Two Blokes Jul 14 - Filed in Stock - 5 views
  
  British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the use of its respiratory syncytial virus (RSV) vaccine to adults under the age of 50 at a higher risk of the disease.